OnKure Therapeutics, Inc. (OKUR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.66
• Market Cap: $36.72M
• EPS: $-4.68
• 52-Week High: $5.60
• 52-Week Low: $1.70

About OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc. is an innovative biopharmaceutical firm dedicated to revolutionizing cancer treatment through the development of precision oncology therapies. Located in Boulder, Colorado, the company utilizes cutting-edge drug discovery platforms to target unmet needs in cancer care, showcasing a strong commitment to personalized medicine. With a diverse pipeline of targeted therapeutic candidates, OnKure is poised to make significant strides in enhancing patient outcomes and resha...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for OnKure Therapeutics, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OKUR pay dividends?

OnKure Therapeutics, Inc. (OKUR) does not currently pay a regular dividend.

What is OKUR's market cap?

OnKure Therapeutics, Inc. (OKUR) has a market capitalization of $36.72M with a current stock price of $2.66.